Urinary Incontinence Case Study

Urinary Incontinence Case Study 

Ruth Olson, a 74 year old female was recently diagnosed with urge urinary continence.  This is caused her a great deal of distress.  She was recently started on a first line treatment regimen for the management of urge urinary incontinence.  She reports dry mouth since starting this medication.

Questions:

  1. What are non-pharmacologic treatment strategies for the management of urge urinary incontinence versus stress urinary incontinence?
  2. What pharmacologic treatment is used first line for a patient with urge urinary incontinence versus stress urinary incontinence (be sure to include, at a minimum, drug name, dose, route, frequency)? What other treatment options exist? Why did you choose your treatment option over other available options (if applicable)?
  3. What is the mechanism of action of EACH selected pharmacologic agent in #2? How does the mechanism of action of EACH medication correlate with the physiology/pathophysiology of urge urinary incontinence and stress urinary incontinence (respectively)?
  4. What are the most common adverse effects of EACH selected medication in #2?
  5. What is the cost of EACH selected treatment option in #2?
  6. Discuss pharmacokinetics and pharmacodynamics of EACH selected pharmacologic agent from #2 (be sure to include, at a minimum, onset, peak, duration, half-life, etc).